← Research
Oct 2022 Randomized Controlled Trial
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial
Bogenschutz MP, Ross S, Bhatt S, et al. — NYU Grossman School of Medicine
Published in JAMA Psychiatry
93 adults with alcohol use disorder received psilocybin or diphenhydramine (active placebo) alongside 12 weeks of manualized therapy. The psilocybin group's heavy-drinking days dropped to 9.7% vs. 23.6% in the placebo group — a 13.9-point gap — with no serious adverse events in the psilocybin arm.
Read the Full Paper at JAMA Psychiatry